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Abstract
Shuttling of proteins between nucleus and cytoplasm in mammalian cells is facilitated by the presence of nuclear
localization signals (NLS) and nuclear export signals (NES), respectively. However, we have found that Tus, an E. coli
replication fork arresting protein, contains separate sequences that function efficiently as NLS and NES in mammalian cell
lines, as judged by cellular location of GFP-fusion proteins. The NLS was localized to a short stretch of 9 amino acids in the
carboxy-terminus of Tus protein. Alterations of any of these basic amino acids almost completely abolished the nuclear
targeting. The NES comprises a cluster of leucine/hydrophobic residues located within 21 amino acids at the amino
terminus of Tus. Finally, we have shown that purified GFP-Tus fusion protein or GFP-Tus NLS fusion protein, when added to
the culture media, was internalized very efficiently into mammalian cells. Thus, Tus is perhaps the first reported bacterial
protein to possess both NLS and NES, and has the capability to transduce protein into mammalian cells.
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Introduction
Replication of the circular E. coli chromosome starts at the
origin of replication (oriC), and proceeds bidirectionally to a region
on the opposite side called Ter, where replication is terminated
[1,2]. Within the Ter region are found ten short (,20 bp) DNA
sequences, called ‘‘Ter’’ sites, which are similar but not identical
(3). Binding of Tus, a 35 kDa trans-acting protein, to the Ter
sequences blocks movement of the DNA replication complex in an
orientation-specific manner: Ter sites (with bound Tus) in the
permissive orientation allow the replication complex to pass,
whereas Tus/Ter complexes in the non-permissive orientation
block its movement [4].
The binding of Tus to the TerB site, with an observed binding
constant (Kobs) of 3–10610
213 M [5], is one of the strongest
known DNA–protein interactions involving a monomeric protein.
The crystal structure of the Tus-Ter complex showed that Tus
protein binds duplex DNA tightly through a novel two-domain
structure with inter-domain b-strands and cannot be released
without a large conformational change of the Tus protein [6]. A
total of 42 amino acid residues out of the 309 amino acids of Tus
interact with the DNA. Of these, 18 residues lie within the b-
strands (FGHI), which lie partially within the major groove of the
Ter DNA, and the remaining 24 residues are dispersed along the
Tus protein between amino acids 50 and 302. Alterations of some
of the amino acids in these domains exhibit partial or complete loss
of DNA binding or DNA replication arrest activity [7,8,9].
In mammalian cells active transport of proteins into the nucleus
is facilitated by the presence of a nuclear localization signal (NLS)
that is recognized by and associated with nuclear import receptors
[10–13]. Similarly, nuclear export of proteins is facilitated by the
presence of a nuclear export signal (NES), in association with an
export receptor, probably CRM-1 [13,14] in human cells.
Although the presence of nuclear targeting sequences are common
in mammalian proteins, the widely used Cre recombinase of
bacteriophage P1 [15] and VirD2 of Agrobacterium [16] are
among only a few prokaryotic proteins known to contain a
sequence that functions as an NLS. However, there was no report
to show that these prokaryotic proteins contain NES, in addition
to NLS in the same protein. We show here with GFP fusion
constructs that the E. coli Tus protein contains both NLS and NES
motifs that function efficiently in human cells. Tus may be the first
prokaryotic protein known to carry both nuclear import and
nuclear export sequences. However, since Tus is a DNA binding
protein, the presence of both NLS in Tus is probably fortuitous;
and thus, the notion of biological significance would be purely
speculative.
Several eukaryotic proteins have the ability to travel through
biological membranes. Examples include the HIV-1 TAT protein,
the herpes simplex virus 1 (HSV-1) DNA-binding protein VP22,
and the Drosophila Antennapedia (Antp) homeotic transcription
factor [17]. The small protein transduction domains (PTDs) from
these proteins can be fused to other macromolecules, peptides, or
proteins to successfully transport them into a cell [17,18]. So far,
there has been no example of any prokaryotic proteins or peptides
derived from prokaryotic proteins to perform a similar function.
Here we show that full-length Tus protein or a peptide (NLS) is
capable of transporting proteins into mammalian cells from the
PLoS ONE | www.plosone.org 1 January 2010 | Volume 5 | Issue 1 | e8889culture media. The NLS and NES of Tus protein may be
important in transducing proteins into mammalian cells.
Methods
Plasmid Constructions
All DNA manipulations were performed using standard
procedures. The wild-type Tus protein gene was cloned from
the E .coli chromosome by PCR using the primers, 59-ATT TTA
GCT AGC GGA GGT GCG CGT TAC GAT CTC GTA GAC
CGA CTC-39 (oligo 1) and 59-TAT ATT CAA TTG TTA ATC
TGC AAC ATA CAG GTG CAG CCG TG-39 (oligo 2)
containing NheI and MunI restriction enzyme sites (underlined),
respectively. The PCR product was cloned into a derivative of a
Gateway destination vector, pDest 47, (Invitrogen) at the NheI-
MunI sites and designated pDest 472-Tus. GFP was cloned into
this vector by site-specific recombination using Gateway (Invitro-
gen) cloning technology. The final expression vector containing
GFP-Tus fusion was under a strong CMV promoter. The entire
fusion construct was verified by sequencing. The plasmid is called
pDest GFP-Tus.
Amino terminal deletion derivatives of Tus protein were cloned
by replacing the full-length Tus from pDest 472-GFP-Tus with
PCR fragments. To clone amino acids 217 to 309 and 264 to 309
of Tus at the end of GFP, oligos 59-ATA TTT GCT AGC GAT
ATC GCT GCC CTG CCA CAG AAC-39 and 59-ATA TT T
GCT AGC ATT AAT CGG GAT AAT GGC GC-39,
respectively were used with oligo 2 above as the 39 oligo for
PCR. The restriction site NheI is underlined. For carboxy terminal
end deletions, oligo 1 (above) was used in conjunction with the
following oligos: 59ATA ATA CAA TTG TTA TAA ATG GCG
GAA ATG ACG CAA CGC 39 (amino acids 1–77), 59ATA ATA
CAA TTG TTA GAG TTC TGA TTC AAC CGT GAC G 39
(amino acids 1–133), 59ATA ATA CAA TTG TTA TGA TTT
CAG GCT TTT TTC CAG CTG TG 39 (amino acids 1–195).
The PCR fragments were cloned at NheI and MunI sites of pDest
472-GFP-Tus to replace the full-length Tus. All clones were
sequence-verified. To clone amino acids 1–217 of Tus, the plasmid
pDest 472-GFP-Tus was cut with EcoRV and MunI, filled in with
Klenow fragment and the largest fragment was self-ligated.
To clone the NLS of Tus, we designed the following oligos: 59-
CTAGCAAGTTAAAAATCAAACGTCCGGTGAAGTAATA-
AC-39 and 59-AATTGTTATTACTTCACCGGACGTTTGA-
TTTTTAACTTG-39. The underlined bases are complementary
to NheI and MunI restriction site following digestion. The oligos
were annealed using standard procedure and ligated to pDest
GFP-Tus digested with NheI and MunI. This replaced the full-
length Tus with the NLS sequence.
We have also generated SV40 NLS (SPKKKRKVE) fused to
GFP to compare with GFP-Tus NLS for protein translocation into
the nucleus. To clone SV40-NLS oligos (upper oligo 59-
CTAGCCCGAAGAAAAAACGTAAAGTGGAGTAATAAC-39
and lower oligo 59-AATTGTTATTACTCCACTTTACGTT-
TTTTCTTCGGG-39) were annealed and ligated to pDest GFP-
Tus similar to Tus NLS as above. The plasmids sequences were
verified and purified; and PC3 cells (ATCC) were transfected by
standard procedure (see below).
Mutation of Tus Proteins
Mutation of Tus was done using the ‘‘QuickChange’’ procedure
developed by Stratagene (California). To change the amino acid
K277 to A227 (K227A), the oligos used were 59-GCTGCCCTG
CCACAGAACGCAGCGCTAAAAATCAAACGTCCGGTG39
(top oligo) and 59-CACCGGACGTTTGATTTTTAGCGCT-
GCGTTCTGTGGCAGGGCA- GC-39 (bottom oligo); a restric-
tion site, AfeI (underlined), was created to screen the mutants. For
the K229A mutation, the oligos were 59- GCCCTGCCACA-
GAACGCGAA GCTAGCAATCAAACGTCCG-GTGAAG-39
(top oligo) and 59CTTCACCGGACGTTT- GATTGCTAGC-
TTCGCGTTCTGTGGCAGGGC-39 (bottom oligo), a restric-
tion site, NheI (underlined), was created to screen mutants. For
K231A, the oligos used were 59- CAGAACGCGAAGTTAAAA-
ATCGCGCGCCCGGTGAAGGTGCAGCCG-39 (top oligo)
and 59- CGGCTGCACCTTCACCGGGCGCGCGATTTT-
TAACTTCG- CGTTCTG-39 (bottom oligo); a restriction
enzyme BssHII site (underlined) was created for screening mu-
tants. For R232A mutation the following oligos were used, 59- CA-
G AAC GCGAAGTTAAAAATCAAGGCGCCGGTGAAG-
GTGCAGCCG-39(top) and 59- CGGCTGCACCTTCACC-
GGCGCCTTGATTTTTAACTTCGCGTTCTG-39, a restric-
tion site, KasI (underlined), was created for easy screening. All
mutations and clones were verified by DNA sequencing.
Cell Culture, Transfection and Microscopy
A human prostate carcinoma cell line PC3 (ATCC) was
cultured in DMEM (Invitrogen) supplemented with 10% FCS
and antibiotics. Cells were plated 24 hours before transfection at
10
6 cell per well (in six-well culture dishes) in final volume of 2 ml
of complete culture medium. The following day, 2 hours before
transfection, culture medium was replaced with 2 ml of fresh,
complete culture medium. Plasmids coding for GFP-Tus fusion
proteins were diluted at 2 mg/10 ml in TE buffer and used for
transfection using the FuGene-6 transfection reagent (Roche
Biochemicals).
After transfection (24 hours), gene expression was monitored
using a set of fluorescence filters specific for GFP detection with
ZEISS fluorescence microscopy. Images were archived using a
SPOT-2 image camera.
Purification of Histidine-Tagged Fusion Protein
E. coli cells containing his-tagged fusion protein were in rich
medium with ampicillin at 100 mg/ml at 30uC. Induction of
expression was done using 1 mM IPTG for 4 hours. Cells were
harvested by centrifugation at 10,000 g at 4uC. Cells were washed
with (equal volume of cell culture) Ni-NTA binding/lysis buffer
(50 mM NaPO4 pH 8.0, 300 mM NaCl, 10 mM immidazole and
20% glycerol). Cells were collected by centrifugation as before.
We resuspended 5 gm of cells in Ni-NTA binding/lysis buffer
(4 ml/gm of cells) containing 2 mg/ml lysozyme and incubated in
an ice bath for 45 minutes, inverting tube every 30 seconds. Cells
were then transferred to 37uC water bath for 5 minutes. Cells were
sonicated 6X with 10 seconds burst, with 10 seconds rest. RNAseA
was added to 10 mg/ml and DNase was added to 5 mg/ml to the
extract. The extract was incubated at 37uC for 5 minutes,
inverting tube every 30 seconds. The extract was transferred to the
ice bath for 5 minutes. The extract was centrifuged at 10,000 g for
30 minutes at 4uC. The supernatant (Fraction I) was collected.
An Ni-NTA column (5 ml) was set up in a cold room and
equilibrated with 5 column volumes of binding buffer. Fraction I
sample was loaded onto column at a flow rate of approximately 1
drop/20 seconds (0.3 ml/minute). Flow-through was collected in a
tube.
The column was washed with 10 column of wash buffer
(binding buffer containing 20 mM immidazole). Unbound/
washed protein was collected in a beaker. Bound protein was
eluted with elution buffer (binding buffer containing 250 mM
immidazole) by collecting 0.3 ml fractions. Each fraction was
checked for protein concentration by a Bio-Rad protein assay,
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maximal peak with the lowest contamination of hi-tagged fusion
proteins were pooled (Fraction II), dialyzed against 500 ml dialysis
buffer (50 mM NaPO4, pH 8.0, 150 mM NaCl, and 20%
glycerol). Protein concentration of the dialyzed Fraction II was
determined. 50 ml aliquots of Fraction II were prepared and stored
at 280uC. We obtained greater than 95% pure Tus fusion protein
using this method.
Delivery of Fusion Protein into PC3 Cells
The PC3 cells were plated at 1610
5 per well in 6-well in tissue
culture plates 24 hours before transduction. The next day, the
culture medium was replaced with 2 ml of fresh medium
containing 7.5 mg Tus-GFP, Tus-GFP-NLS, Tus-Cre, or TAT-
Cre protein to each well. For control experiments, we treated the
cells with the same amount of GFP (without NLS). At indicated
time points, cells were washed in PBS, and the green fluorescence
was observed under fluorescence microscopy.
DAPI Staining
Plates containing adherent cells were washed with PBS, and
fresh PBS supplemented with DAPI at 1:1000 dilution of stock
solution (1 mg/mL) was added to plates; plates were incubated
for10 minutes in tissue culture incubator. After this time, plates
were washed again with PBS, and fresh, complete culture medium
was added. The blue fluorescence was detected under fluorescence
microscopy using a DAPI filter.
Results and Discussion
Nuclear Import and Export of GFP-Tus Fusion
The Tus protein was fused to the carboxy terminus of GFP, as
described in Materials and Methods. The fusion was made
initially as a model to develop a novel protein microarray-on-
demand technology [19]. For this purpose, we wanted to ex-
amine the expression of the GFP fusion in mammalian cells by
transient expression. GFP expression (pDest 472-GFP) in PC3
cells alone showed fluorescence distributed throughout the cells
(Figure 1A[a]). In contrast, transfection of PC3 cells with pDest
472-GFP-Tus resulted in strong green fluorescence almost
exclusively in the nucleus of the cells (Figure 1A[b]). On the
other hand, GFP fusion of the carboxy-end deleted version of Tus
showed localization of the fusion protein to cytoplasm of PC3
cells (Figure 1[c]). To conclusively determine nuclear localization
of GFP-Tus protein, following transfection, cells were examined
for green fluorescence, as well as for DAPI nuclear staining. The
results as shown in Figure 1B and 1C clearly suggest that GFP-
Tus fusion protein is indeed localized in the nucleus. Since Tus
is a bacterial protein, specific targeting to the nucleus was
unexpected. Nuclear pores in eukaryotic cells consist of 9–
10 nm-diameter channels that might allow smaller proteins
(,40 kDa), to diffuse in and out of the nucleus freely, but import
of larger proteins is an active process [12]. The size of the GFP-
Tus fusion protein is about 62 kDa and thus, it would be difficult
for this large fusion protein to pass the nuclear membrane by
simple diffusion. In addition, to show that nuclear or cytoplasmic
localization is due to the presence of Tus or of a carboxy-end
deleted version of Tus, respectively, we cloned GFP with another
protein, tetR, which has no known NLS on NES with GFP. As
c a nb es e e ni nF i g u r e1 ( d ) ,t h eG F Pf l u o r e s c e n c ei sp r e s e n ta l l
over the cells. The results suggest that specific localization of the
GFP fusion protein is due to the presence of the NLS and NES
sequence in Tus.
Location of Nuclear Localization Signal in Tus
To identify the location of the nuclear localization signal (NLS)
within Tus, we constructed a series of N- and C-terminal deletion
mutants of Tus, which were fused to GFP to determine the
subcellular distribution of green fluorescence in the PC3 cell line.
Transfection of PC3 cell lines with all of these fusion constructs
was performed, and the results are summarized in Figure 2A.
The results suggest that fusion of up to 217 amino acids from
the N-terminus of Tus protein (full-length 309 amino acids) with
GFP causes loss of nuclear targeting. However, the fusion of amino
acids 218 to 309 of Tus to the C-terminus of GFP restored nuclear
targeting. Thus, the nuclear targeting signal must be located
within the 92 amino acids at the C-terminus of Tus. Fusion of the
Tus fragment corresponding to amino acids 264 to 309 with GFP
did not result in nuclear targeting. Therefore, the location of the
Figure 1. Subcellular localization of GFP and GFP-Tus deriva-
tives. A Panel (a), GFP only; Panel (b), GFP-TUS is the fusion of GFP with
full-length Tus; Panel (c), GFP-TUS-DC is GFP-fused with amino acids Tus
containing 1–217 of Tus; (d), GFP-TetR is the fusion of GFP with a non
specific protein, tetR. B. Panel (a), GFP fluorescence of GFP-Tus protein;
Panel (b), cells were stained with DAPI; and Panel (c), Superimposition
of panels (a) and (b). C. Cytoplasmic localization of GFP fused with 1–
217 amino acids of Tus. Panel (a), GFP fluorescence; Panel (b), DAPI
staining; and Panel (c), Superimposition of panels (a) and (b).
doi:10.1371/journal.pone.0008889.g001
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carboxy end of Tus.
Nuclear localization signals do not fit a tight consensus but
generally fall into two classes: short stretches of four to seven basic
(SV40 type) amino acids [18]; and longer bipartite sequences
comprising two stretches of basic amino acids separated by several
less conserved spacer amino acids [20]. We did not detect any
bipartite-like nuclear localization sequences within amino acids
218 to 264. However, after scanning the amino acid sequence, we
detected a short stretch of basic amino acids resembling an NLS-
like sequence of KLKIKRPVK (amino acids 227–235) as shown
in Figure 2B. We speculated that this sequence might be the
putative nuclear targeting signal in Tus. In the crystal structure of
Tus, this region is present in the b-strand H, one of the
interdomains of Tus protein that forms the main elements of Ter
DNA sequence recognition.
Mapping of Nuclear Localization Signal (NLS)
To further demonstrate the importance of the basic amino
acids in the putative NLS-like sequence, we systematically
mutated them and examined the subcellular distribution of green
fluorescence following transfection into PC3 cells. The construct
used for the mutation contains amino acids 218–309 of Tus fused
to GFP. As can be seen in Figure 3A, alteration of any one of the
basic amino acids resulted in pronounced perturbation of nuclear
targeting of the fusion proteins. These results suggest that each of
these basic amino acids plays a crucial role in nuclear transport.
Finally, we cloned amino acids KLKIKRPVK (amino acids 227
to 235), at the end of GFP and showed that these amino acids are
all that is needed for nuclear transport of GFP (Figure 3B). For
comparison with a positive control, we also cloned a SV40 NLS,
a highly characterized NLS motif, similar to Tus NLS with GFP.
As can be seen, GFP fluorescence is very similar in both cases
(Figure 3B), suggesting that both NLS sequences function
similarly.
It has been proposed that NLS sequences often overlap with the
nucleic acid binding domain of proteins [21]. It is true that the
residues KLKIKRPVK of Tus protein are indeed involved in
interacting with ter sequences [8]. However, our tests show it is
very unlikely that the DNA binding activity of Tus is essential for
nuclear targeting. Purified GFP fusion protein containing Tus
residues 218–309 showed no apparent binding affinity towards Ter
Figure 2. A. Localization of NLS and NES determinants of Tus by deletion analysis. A. Full-length and various deletions of Tus were fused
with GFP, and localization of the fusion protein in nucleus (N), cytoplasm (C), and all over the cell (C+N) were indicated on right. The boundary of the
NLS region was between amino acids 218 and 264 and the boundary of the NES region was between 1 and 77 amino acids. B. Comparison of various
types of known NLS with putative NLS sequence of Tus.
doi:10.1371/journal.pone.0008889.g002
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nucleus. The loss of Ter binding activity was expected, since
important amino acids in the interdomain b-strands FG [8] and at
other locations in the Tus protein were missing in the deleted
construct. Thus, our results suggest that for nuclear targeting, the
NLS sequence must have basic amino acids but need not bind
nucleic acids.
A bacteriophage DNA binding protein, Cre, and VirD2 of
Agrobacterium were shown to possess NLS sequences [16,22].
However, unlike Tus, Cre has a bipartite-like NLS sequence and
VirD2 has both mono- and a bipartite-like NLS sequence. There
are some other subtle differences with respect to the location of
NLS in these two proteins. In VirD2, the NLS is present at the
carboxy terminus, while in the Cre, the bipartite-like NLS is
present at the amino terminus. In VirD2, two regions encompass-
ing 417–420 and 430–434 were needed for NLS function.
However, Cre needs two long regions, Region I and Region II,
encompassing about 172 (100–271) amino acids for nuclear
targeting. Interestingly, Tus only needs a short stretch of basic
amino acids for nuclear targeting, very similar to most mamma-
lian-type NLS sequences. Active nuclear import of proteins is
believed to occur in two steps: binding to cytoplasmic surface of
the nuclear pore complex, followed by the energy-dependent
translocation into the nucleus [9,14,23]. Experiments are under-
way to understand the mechanism of nuclear transport in
eukaryotic cells mediated by Tus.
Identification of Nuclear Export Signal (NES)
While we were mapping the NLS region of Tus, we noticed that
deletion of the carboxy terminus (GFP-Tus DC, amino acids 218
to 309) caused fluorescence of GFP to concentrate mainly in the
cytoplasm (Figure 1). This result suggested the presence of a
nuclear export signal (NES) within the first 217 amino acids of
Tus. To narrow down the region required for nuclear export,
further deletions were made and the distribution of fluorescence
was assessed. As can be seen in Figure 2, the NES region is located
within the first 77 amino acids of Tus. We examined the primary
amino acid sequence of Tus in the first 77 amino acids to
determine whether it contains a leucine-rich sequence with
hydrophobicity, which is the hallmark criterion established for
an NES [13,20,24]. A possible consensus nuclear export sequence
is LX 1–3 LX 2–3 LXL, where L=leucine and X=any amino acid
and the last leucine can be replaced by conservative substitutions
(isoleucine, valine, etc.). A careful examination of the Tus amino
acids sequence showed the presence of several candidate regions.
To localize the NES region, several regions of Tus within the first
77 amino acids were cloned at the carboxy terminus of GFP
(Figure 4A). The clones containing GFP fused with indicated
amino acids portion of Tus were transfected into PC3 cell lines
and the distribution of GFP was observed. As indicated in
Figure 4A, the NES was localized within 21 amino acids (amino
acids 21 and 41 of Tus). Deletion of leucine residue from either
end of 21 amino acids abolished the NES function. It appears that
all 21 amino acids seem to be required for NES to function. This
region contains several clusters of leucine and other hydrophobic
amino acids that are hallmarks of NES (Figure 4B). Finally, we
have shown that mutation of amino acids L33A and L34A almost
completely abolished the function of NES, suggesting the
important roles of leucine in NES function (Figure 4C). However,
the length of Tus NES is slightly longer than other known NES
sequences.
Similar to nuclear import, nuclear export is also thought to use
the nuclear pore complexes for exporting large proteins
[25,26,27,28]. However, compared to nuclear import, nuclear
export is poorly understood. Some proteins that need to shuttle
between the nucleus and cytoplasm through the nuclear pore
contain both NLS and NES [27,28]. Examples include the Rev
protein of HIV1 and the nuclear factor of activated T cells
(NFAT). The Rev protein plays a key role in the regulation of viral
expression. NFAT is the target of immunosuppressive drugs widely
used in organ transplantation. However, the presence of both NLS
and NES in a bacterial protein is unexpected and very unusual, as
there is no nuclear membrane for protein translocation between
nucleus and cytoplasm.
To understand the mechanism of nuclear export of Tus, we
examined the effect of leptomycin, an inhibitor of CRM-1 [13,14]
mediated nuclear export. Our result indicates that Tus NES is
probably exported through other mechanism unknown to us at
this time. It is possible the Tus uses the same mechanism used by
two other known proteins, Tax protein of HTLV-1 [29] and
Smad3 [30]. Both proteins contain similar leucine-rich NES for
nuclear export as Tus.
Protein Delivery by Tus and Tus-NLS Functions Similar to
TAT
The direct introduction of proteins into cells may be useful to
study cell cycle regulation, control of apoptosis, and transcription
regulation. In addition, protein transduction has been shown to
be an effective and safer way of delivering biologically active
proteins into cells to correct diseases. The plasma membrane is
the natural barrier that excludes proteins among other molecules
Figure 3. Mutational analysis of NLS region of Tus. Mutation was
done using a plasmid containing GFP fused to Tus (218–309) expressed
in PC3 cells. Expression of only GFP was shown in the top left panel.
Localization of un-mutated GFP-Tus (218–309) fusion was shown in the
upper right panel. Mutants (indicated) of specific amino acids Tus
within 218–309 amino acids fused to GFP were expressed in PC3 cells.
B. Tus-NLS region containing 9 amino acids and SV40-NLS was fused to
GFP expressed in PC3 cells (positive control).
doi:10.1371/journal.pone.0008889.g003
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protein delivery systems. Over the years, several proteins,
including HIV-1 TAT, HSV1-VP22, and Drosophila-Antp, and
peptides derived from those proteins have been shown to have the
capability to travel (transduce) through plasma membranes
[17,31,32]. However, most of the internalized proteins end up
in endosomal vesicles, and only a small portion were shown to be
released. All of these proteins and peptides were derived from
eukaryotic sources. To date, there has been no example of any
bacterial protein(s) possessing similar attributes. Cre, though it
contains a putative NLS sequence, has been shown to transduce
very poorly unless it was fused to TAT and another NLS
sequence [33]. To our surprise, we have repeatedly found that
when purified GFP-Tus fusion protein (,62 kDa) was included in
the culture media, the fusion protein was internalized very rapidly
into the PC3 (prostate cancer) human cell line (Figure 5A).
Similarly, fusion protein containing GFP plus a 9-amino acid
NLS sequence of Tus has similar activity and helps transduce the
GFP passenger protein from the culture media to inside of PC3
cells in a time-dependent manner (Figure 5B and C). In contrast,
no internalization (GFP fluorescence) was observed when equal
amount of purified GFP (without NLS) was used under identical
condition (Figure 5D).
We have demonstrated the presence of both nuclear targeting
(NLS) and nuclear exporting (NES) signals within a single bacterial
protein, Tus. This perhaps is the first known bacterial protein to
contain both signals normally present in some mammalian
proteins required for shuttling between nucleus and cytoplasm.
Both NLS and NES contain putative consensus-like sequences.
Why would a bacterial protein like Tus contain determinants that
efficiently direct it towards the nucleus or the cytoplasm? Since
Tus is a DNA binding protein, initially it was thought to be
fortuitous and perhaps due to simple diffusion. However, our
results suggest that Tus indeed contains a putative NLS signal and
that mutations of essential amino acids in this sequence completely
abolished nuclear targeting. NLS sequences often overlap with
DNA binding regions. Although the putative NLS region
identified in Tus contains some DNA (Ter) binding amino acids,
we have shown that DNA binding is not essential for nuclear
targeting. However, the biological significance of the presence of
both NLS and NLS in Tus is not known and any suggestions
would be speculative.
It is also noteworthy that full-length Tus fused to GFP directs
mostly in the nucleus, suggesting that the NLS is a dominant
signal, compared to NES. In a blast search (NCBI GCG-Lite plus
parallel Fasta search for protein sequence), we have found that the
21-amino acids NES of Tus has a sequence identity of about 83%
with both human and mouse transcription factor (E2F6) and about
75% identity with human and mouse nuclear factor of kappa light
polypeptide gene enhancer in B-cells 2 (NFKb2) and Drosophila
DNA polymerase subunit a B. In addition, it has various levels of
identity with many more human and other mammalian proteins.
We do not know if there is any relevance to this similarity. In
addition, at this time, we do not know of any biological reasons or
significance for the presence of these unusual properties in Tus.
We are currently investigating if there is any biological relevance
of this discovery.
In addition to finding NLS and NES in Tus protein, our
experiments suggest that full-length Tus and its 9-residue NLS
peptides may be useful for protein delivery into mammalian cells.
GFP fused to either full-length or its NLS is capable of
internalization in PC3 or 293 cells (ATCC) within 2 hours after
the addition of fusion proteins. We believe that this is the first
example of a bacterial protein-mediated protein delivery into
mammalian cells and may be added to the list of known
mammalian proteins with similar attributes. At this time, we do
not know of any biological significance of Tus having NLS or
NES. It is possible that the presence is completely fortuitous.
Currently, extensive study is being done to elucidate the
mechanism of protein transport and release of passenger protein
from the endosomal vesicle.
Acknowledgments
Authors thank Dr. Dhruba K. Chattoraj for critical reading of the
manuscript.
Figure 4. A. Location of NES sequence, comparison of various
NES and mutational analysis of NES region of Tus. A.
Replacement of full-length Tus in pDest 472 GFP-Tus vector with the
indicated region of Tus was used to localize the region of NES. B.
Comparison of Tus NES with known NES (p53, HIV Rev and PKI) were
shown. Amino acids in red indicate leucine, and isoleucine residues are
hallmarks of NES. C. Effect of mutation of leucine 33 and 34 in NES
function. (a) Localization of GFP-Tus (1–77) and (b) GFP-Tus (1–77:L33A–
L34A double mutants) in PC3 cells. D. Distribution of GFP proteins in
PC3 cell line.
doi:10.1371/journal.pone.0008889.g004
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